scholarly journals Human albumin solution for resuscitation and volume expansion in critically ill patients

Author(s):  
Ian Roberts ◽  
Karen Blackhall ◽  
Phil Alderson ◽  
Frances Bunn ◽  
Gillian Schierhout
2006 ◽  
Vol 1 (3) ◽  
pp. 243-245 ◽  
Author(s):  
Alessandro Liberati ◽  
Lorenzo Moja ◽  
Ivan Moschetti ◽  
Gian Franco Gensini ◽  
Roberto Gusinu

1987 ◽  
Vol 10 (3) ◽  
pp. 199-204 ◽  
Author(s):  
B.K. Krämer ◽  
O. Ickrath ◽  
G. Keppler ◽  
K.M. Ress ◽  
T. Risler

The present study examined the effects of repeated plasma exchanges with membrane filtration (Plasmaflux P2 membrane, 4.3 I human albumin solution) on the hemostatic system and on thyroid hormones in critically ill patients. Clotting factors V, VII, VIII, IX, X, XI, XII, XIII, fibrinogen, antithrombin III (ATIII), prothrombin time (PT), activated partial thromboplastin time (PTT), total (TT3) and free tri-iodothyronine (FT3), total (TT4) and free thyroxine (FT4), and thyroxine binding globulin (TBG) were determined before, immediately after, 1, 3, 6 and 24 h after plasma exchange in 6 patients (3 with glomerulonephritis, 2 with IgG myeloma, 1 with chronic polyneuritis) during 18 plasma exchanges. After plasma exchange levels of clotting factors and ATIII were markedly lowered but except for fibrinogen and factor XIII, they were not reduced by repeated exchange procedures. Thyroid hormones and TBG were reconstituted after 24 h. Pre-exchange levels, except for TT4 and TBG, were not lowered by repeated exchange procedures. Risk of bleeding or thrombosis is small and there is no appreciable risk of loss of thyroid hormones during repeated plasma exchanges.


2020 ◽  
pp. 175114372096124
Author(s):  
David Melia ◽  
Benjamin Post

Albumin plays a key role in the critically ill patient acting as a prognostic marker and as a therapy in the form of human albumin solutions. However, the use of human albumin solution has varied over time with notable differences between health systems. Whilst its use is widely accepted for some clinical indications, its role has not always been clear in the critically ill and has been found to be harmful in some cohorts. Numerous studies have showed conflicting results and critical care clinicians have not always been guided by robust evidence. Nonetheless, at present the use of human albumin solution appears to be increasing again in the United Kingdom. Below, we discuss the latest evidence base for its use in critically ill patients.


Sign in / Sign up

Export Citation Format

Share Document